Medicare Part D SHOCKER: CMS Rejects Plans for 2026! What You Must Know Now
CMS rejects standalone Part D plan bids due to high premium increases, signaling major 2026 Medicare Part D changes affecting existing members and prescription drug coverage.
Key Takeaways
- If your standalone Part D plan is rejected, you'll receive a letter with transition details; do nothing and you'll be auto-enrolled in a different plan, or you must actively select a new plan by the October 15 enrollment deadline
- Start comparing Part D plans on October 1 (when Medicare.gov Plan Finder updates) rather than waiting until October 15 to have maximum time to review changes and price increases
- Expect higher out-of-pocket prescription drug costs in 2026 due to limited plan availability, increased drug prices (especially GLP-1 weight loss medications), and fewer carriers offering Part D coverage
- If you have employer-provided health coverage and are Medicare-eligible, watch for notifications about whether your employer plan still meets Medicare's credible coverage standard, as some plans may drop prescription drug benefits to stay within budget
- Read your Annual Notice of Change letter carefully when it arrives to understand what premiums, deductibles, and formulary changes will affect your current plan in 2026
Medicare Part D 2026 Changes: What You Need to Know
For the first time ever, the Centers for Medicare and Medicaid Services (CMS) has rejected bids from standalone Part D plans due to unacceptable year-over-year premium increases. This unprecedented move signals significant Medicare Part D 2026 changes that could impact millions of beneficiaries.
Jae Oh, CFP, author of Maximize Your Medicare, joins Robert Powell to explain how this will create disruption for existing Part D members. If your plan is affected, you could be transitioned automatically or forced to shop for a new Part D plan in 2026. It’s important to note that this decision specifically impacts standalone Part D plans, which operate on annual contracts, and not bundled Medicare Advantage plans.
This isn’t the only major development. Expect higher out-of-pocket costs for Medicare Part D prescriptions, partly driven by rising drug prices, including popular medications like Wegovy. In addition, drug price negotiations for at least 10 drugs under Medicare Part D will begin in 2026, adding more complexity for both patients and providers. The definition of what qualifies as creditable coverage for employer-provided prescription drug plans may also change in 2026, potentially affecting Medicare-eligible employees who still receive coverage through work.
Don’t get caught off guard! If you have a standalone Part D plan, carefully review your Annual Notice of Change (ANOC) letter, which you are guaranteed to receive by federal rule. Starting October 1st, 2025, you can use Medicare.gov’s Plan Finder to compare your options for 2026. The Annual Election Period begins October 15th, giving you the chance to switch or update your coverage.
The year 2026 is shaping up to be one of the most eventful in Medicare history, with a complex tug-of-war between carriers, pharmaceutical companies, and retailers. Staying informed and proactive will be key to protecting your health and your wallet.
Subscribe to our channel for the latest Medicare updates and expert insights to navigate these changes. Be sure to check out our other videos for more strategies to maximize your Medicare benefits.
#MedicarePartD #CMS #2026Medicare #PrescriptionDrugs #MedicareUpdates #StandalonePartD #AnnualElectionPeriod #JaeOh